Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substancesArticle Published on 2022-11-012022-11-15 Journal: Environment international [Category] 진단, [키워드] 95% CI adjusted affected analyses Analysis anti-Spike IgG antibody antigenic association coefficient comparable Concentration confidence interval Coronavirus disease 2019 COVID-19 COVID-19 antibody COVID-19 vaccination COVID-19 vaccine disease Enrollment examined follow-up study group Human IgG increase in interquartile range magnitude neutralizing antibody observation Occurrence other variables participant Perfluoroalkyl substances PFAS Polyfluoroalkyl substances recent reduced repeated measure reported response serum shown spring sulfonic acid Tetanus vaccination Vaccine vaccine-induced antibody vaccine. [DOI] 10.1016/j.envint.2022.107537 PMC 바로가기
Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registryArticle Published on 2022-11-012022-11-16 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 치료기술, [키워드] aetiology Affect analysed analyses approved caused Characteristics containment measures COVID-19 COVID-19 pandemic COVID-19 patient disease fear Healthcare system hospital Impact impacted In-hospital incidence less management multicentre neurological no infection occurred outcome pandemic Patient patients retrospective SARS-CoV-2 SARS-COV-2 infection Seizure status epilepticus status epilepticus. transfer transmitted Treatment Trial university Variation Vascular [DOI] 10.1007/s00415-022-11260-2 PMC 바로가기
One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021Article Published on 2022-10-312022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] analyses clade Clinical data clone collected Community conducted contributed defined Delta Evidence facilitate Genome genomic genomic data Genomic surveillance Health identify infectious disease outbreak Lineage local public health Mutation new SARS-CoV-2 occurred one health outbreak phylogenetic analysis positive provided public health RT-qPCR SARS-CoV-2 SARS-CoV-2 genome secondary transmission sequenced single mutation Spread spread of COVID-19 subsequent subset Surveillance targeted interventions the SARS-CoV-2 through contact variant variants was tested wastewater were used [DOI] 10.1371/journal.pone.0272830 PMC 바로가기
Influence of COVID-19 pandemic on the decision making of patients in undergoing gamma knife radiosurgeryArticle Published on 2022-10-292022-11-16 Journal: European Journal of Medical Research [Category] 변종, [키워드] affected age analyses analyzed approach approval attenuate characteristic co-morbidity collected Comorbidity control group COVID-19 COVID-19 pandemic COVID-19 vaccination database decision Decision making Diagnosis Follow-up Frequency Gamma Gamma knife influence lesion lesions less MRI neurological Neurological deficit pandemic parameter Patient patients treated performance proportion Radiation Radiation dose Radiosurgery Sex status time interval treated Treatment vaccination vaccination. variant Volume [DOI] 10.1186/s40001-022-00859-w PMC 바로가기
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 OutpatientsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] acting acute respiratory syndrome added Administered administration Amplicon sequencing analyses Analysis antibody Antiviral antiviral property antiviral strategy applied Bacteria benefit Care chills collected Combined coronavirus coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients detectable Diagnosis diarrhea double-blind dried blood spot eligible evaluated Fever Health hospital Hospitalization infected with SARS-CoV-2 Lactobacillaceae lactobacilli Microbiome modulation multifactorial nasopharyngeal viral load nose-throat swab online questionnaire Outpatient Pain Patient per-protocol analysis Placebo placebo-controlled trial positive potential mechanism practitioners qPCR quantitative PCR Randomized reduce reducing reported reported symptom respiratory tract infection respiratory viral disease SARS-CoV-2 selected sequence severity significantly spray strain Symptom symptom resolution the patient the placebo group therapy Throat throat spray. Treatment Trial trials upper respiratory tract Vaccines variant Viral diseases viral infection Viral load was performed [DOI] 10.1128/spectrum.01682-22 PMC 바로가기
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyArticle Published on 2022-10-252022-11-16 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI age Alpha analyses children clinical Community concern coronavirus 2 COVID-19 COVID-19 infection COVID-19 severity diagnosed with COVID-19 FIVE Frequency Gamma Hospitalization ICU admission illness Illumina immunization incidence increasing age marker medical condition Medical conditions outcome outcomes performed pharmacologic treatment prevented recent Regression model respiratory Respiratory Support retrospective cohort study SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant scale Sequencing severe COVID-19 severe disease severity Severity. single-center the WHO VoC VOCs were infected with COVID-19 [DOI] 10.1093/jpids/piac068 PMC 바로가기
Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional studyArticle Published on 2022-10-242022-11-15 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Accuracy Ag-RDT Ag-RDTs analyses Antigen antigen detection antigen test asymptomatic individual COVID-19 cross-sectional cross-sectional study cut-off diagnostic Diagnostic accuracy diagnostic test Diagnostic test accuracy E-gene General population individual Interpretation molecular molecular test MOST nasal Nasal test Negative predictive value participant Participants positive Positive predictive value presenting public health Rapid rapid antigen detection test Roche Diagnostics Saliva Saliva test. SARS-CoV-2 SARS-CoV-2 detection SARS-COV-2 infection SARS-CoV-2 testing SD Biosensor sensitivity subgroups Symptom symptomatic and asymptomatic Viral load [DOI] 10.1186/s12916-022-02603-x PMC 바로가기
Impact of the New Coronavirus Infection on the Immune System of Children and Adolescents in the Region of the Russian FederationArticle Published on 2022-10-212022-11-15 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 진단, [키워드] absence Active disease Adolescent age analysed analyses Analysis biochemical carried categories caused CD3+CD4+ cellular immunity changes in children Clinical features consequence COVID-19 deviation Diagnosis disease disease stage Epidemiology Federation FIVE flow cytometry group growth Human immune system IgA IgG IgG and IgM IgM Immune status immune system Immunity Immunoglobulin immunograms immunological immunology immunology. immunoregulation Impact Infection interval introduced laboratory diagnosis lack leukocytes Lymphocytes methodology Mutation New New coronavirus NK cell pandemic pathogen Patient patients Perm Krai phagocytic phagocytosis professional public health QR code Quantitative analysis Racial Region Research Russian population SARS-CoV-2 SARS-CoV-2 vaccination selected serological severity System T helper the disease Treatment was performed [DOI] 10.3390/ijerph192013669 PMC 바로가기
Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic AnalysesArticle Published on 2022-10-182022-11-16 Journal: Viruses [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] addition analyses Analysis benefit BMI C-reactive protein Cluster cluster analysis Control COVID-19 CRP death ECDC European Factor frailty Genome sequencing genomic Genomic analysis genomic data HAI healthcare worker healthcare-associated COVID-19 Hospital-acquired infection identify Infection management Model Negative predictive value nosocomial outbreak NPV pandemic Patient performed Positive predictive value PPV predict prediction prediction modelling. ROC SARS-CoV-2 SARS-COV-2 infection significantly thrombocyte university hospital variable [DOI] 10.3390/v14102292 PMC 바로가기
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesArticle Published on 2022-10-152022-11-16 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyses analysis Analysis aRR association B.1.1.529 benefit BNT162b2 booster booster dose Booster vaccine calculated ChAdOx1 nCoV-19 Chronic kidney disease Committee Comorbidities Comorbidity conducted core covariates COVID-19 COVID-19 hospitalisation COVID-19 infection COVID-19 therapeutics COVID-19 vaccination current death dominant Edinburgh England event group Health health condition high risk hospitalisation identify immunisation Immunosuppressant increased risk individual initial Innovation Ireland male Medical Research Council meta-analyses Moderna mortality data mRNA-1273 Multimorbidity National of BNT162b2 offer older adult outcome outcomes Oxford-AstraZeneca per 1000 person-year per 1000 person-years Pfizer-BioNTech Poisson regression model primary care prospective cohort prospective cohort study rate ratio receiving reduced reduced risk remained risk risk factor RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 Sex those with comorbidity university vaccination Vaccine vaccine dose vaccine group variant [DOI] 10.1016/S0140-6736(22)01656-7 PMC 바로가기